Overigens is diabetes-2 meestal te genezen via een gezonde leefstijl met veel bewegen en sporten plus aangepast voedingspatroon met veel groenten en fruit en soms vette vis. Mensen met diabetes-2 krijgen dit ook vergoed en kunnen een gezondheidsprogramma volgen onder begeleiding. Zie ook dit artikel op onze website.
14 december 2024: Bron: GUT
Uit studiegegevens gepubliceerd in GUT stellen de onderzoekers dat het natuurlijke alkaloid Harmine (Harmijn) via de betacellen de insulineproductie herstelt. Wat zou betekenen dat diabetes, zowel diabetes 1 als 2 te genezen zou zijn met dit medicijn. Harmine (Harmijn) maakt deel uit van een groep medicijnen die DYRK1A-remmers worden genoemd en al eerder werden deze medicijnen gelinkt aan herstel van de insulineproductie. In een nieuwe studie herstelde Harmine (Harmijn) samen met GLP-1-receptoragonisten zoals semaglutide en exenatide de productie van insuline via de bèta-cellen.
De onderzoekers onder leiding van prof. dr. Esra Karakose voerden in het verleden verschillende laboratoriumstudies uit en hebben nu een dierstudie met muizen zonder immuunsysteem opgezet die opmerkelijke resultaten laat zien. De onderzoekers transplanteerden een klein aantal menselijke bètacellen in muizen zonder immuunsysteem, een situatie dat in principe model staat voor diabetes type 1 en type 2. De muizen werden behandeld met de combinatietherapie van Harmine (Harmijn) samen met GLP-1-receptoragonisten. Wat de onderzoekers zagen was heel opmerkelijk want binnen drie maanden na de start van de behandeling kwam de insulineproductie weer op gang en verdween de diabetes. Wat nog belangrijker lijkt is dat het aantal menselijke bètacellen met 700 procent toe nam mede onder invloed van alfacellen die veelvuldig voorkomen in de alvleesklier. Blijkbaar spelen deze alfacellen een grote rol in het nieuw produceren van menselijke bètacellen. Aldus schrijven de onderzoekers in hun studieverslag.
De ontdekking dat alfacellen in de alvleesklier kunnen worden omgezet in bèta-cellen biedt nieuwe hoop voor zowel type 1 als type 2 diabetespatiënten. “Dit is een heel belangrijke ontdekking die laat zien dat medicijnen uit de harmine-familie mogelijk de omzetting van cellen in de menselijke eilandjes van Langerhans kunnen stimuleren”, aldus onderzoeker Esra Karakose in een toelichting op hun studiepresentatie. “Dit zou betekenen dat mensen met alle vormen van diabetes veel potentiële bèta-cellen hebben, die zouden geactiveerd kunnen worden door medicijnen zoals Harmine (Harmijn) al of niet in combinatie met andere medicijnen.”
Het volledige studieverslag is gratis in te zien of te downloaden. Klik daarvoor op de titel van het abstract:
Supplemental information (4)
Document S1. Figures S1–S8 and Tables S3 and S4
Table S1. Excel file containing the list of upregulated genes in the Cycling Alpha cluster vs. all other clusters, related to Figure 4
Table S2. Excel file containing the list of upregulated genes in clusters 0-1-2 of the Cycling Alpha cluster, related to Figure 5
Document S2. Article plus supplemental information
References
2.
Karakose, E. ∙ Ackeifi, C. ∙ Wang, P. ...
Advances in drug discovery for human beta cell regeneration
Diabetologia. 2018; 61:1693-16993.
Dirice, E. ∙ Walpita, D. ∙ Vetere, A. ...
Inhibition of DYRK1A Stimulates Human beta-Cell Proliferation
Diabetes. 2016; 65:1660-16714.
Abdolazimi, Y. ∙ Zhao, Z. ∙ Lee, S. ...
CC-401 Promotes beta-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition
Endocrinology. 2018; 159:3143-31575.
Shen, W. ∙ Taylor, B. ∙ Jin, Q. ...
Inhibition of DYRK1A and GSK3B induces human beta-cell proliferation
Nat. Commun. 2015; 6:83726.
Aamodt, K.I. ∙ Aramandla, R. ∙ Brown, J.J. ...
Development of a reliable automated screening system to identify small molecules and biologics that promote human beta-cell regeneration
Am. J. Physiol. Endocrinol. Metab. 2016; 311:E859-E8687.
Wang, P. ∙ Alvarez-Perez, J.C. ∙ Felsenfeld, D.P. ...
A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication
Nat. Med. 2015; 21:383-3888.
Ackeifi, C. ∙ Wang, P. ∙ Karakose, E. ...
GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration
Sci. Transl. Med. 2020; 12, eaaw99969.
Ackeifi, C. ∙ Swartz, E. ∙ Kumar, K. ...
Pharmacologic and genetic approaches define human pancreatic beta cell mitogenic targets of DYRK1A inhibitors
JCI Insight. 2020; 5, e13259410.
Wang, P. ∙ Karakose, E. ∙ Liu, H. ...
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Cell Metabol. 2019; 29:638-652.e511.
Kumar, K. ∙ Wang, P. ∙ Wilson, J. ...
Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human beta-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor
J. Med. Chem. 2020; 63:2986-300312.
Dhawan, S. ∙ Dirice, E. ∙ Kulkarni, R.N. ...
Inhibition of TGF-beta Signaling Promotes Human Pancreatic beta-Cell Replication
Diabetes. 2016; 65:1208-121813.
Liu, Y.A. ∙ Jin, Q. ∙ Zou, Y. ...
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133
J. Med. Chem. 2020; 63:2958-297314.
Wang, Y.J. ∙ Golson, M.L. ∙ Schug, J. ...
Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas
Cell Metabol. 2016; 24:616-62615.
Rosselot, C. ∙ Li, Y. ∙ Wang, P. ...
Harmine and exendin-4 combination therapy safely expands human beta cell mass in vivo in a mouse xenograft system
Sci. Transl. Med. 2024; 16, eadg345616.
Thorel, F. ∙ Népote, V. ∙ Avril, I. ...
Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss
Nature. 2010; 464:1149-115417.
Chera, S. ∙ Baronnier, D. ∙ Ghila, L. ...
Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers
Nature. 2014; 514:503-50718.
Nir, T. ∙ Melton, D.A. ∙ Dor, Y.
Recovery from diabetes in mice by beta cell regeneration
J. Clin. Invest. 2007; 117:2553-256119.
Furuyama, K. ∙ Chera, S. ∙ van Gurp, L. ...
Diabetes relief in mice by glucose-sensing insulin-secreting human alpha-cells
Nature. 2019; 567:43-4820.
Lee, S. ∙ Zhang, J. ∙ Saravanakumar, S. ...
Virgin beta-Cells at the Neogenic Niche Proliferate Normally and Mature Slowly
Diabetes. 2021; 70:1070-108321.
van der Meulen, T. ∙ Mawla, A.M. ∙ DiGruccio, M.R. ...
Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets
Cell Metabol. 2017; 25:911-926.e622.
Lam, C.J. ∙ Cox, A.R. ∙ Jacobson, D.R. ...
Highly Proliferative alpha-Cell-Related Islet Endocrine Cells in Human Pancreata
Diabetes. 2018; 67:674-68623.
Minami, K. ∙ Okuno, M. ∙ Miyawaki, K. ...
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells
Proc. Natl. Acad. Sci. USA. 2005; 102:15116-1512124.
Dirice, E. ∙ Basile, G. ∙ Kahraman, S. ...
Single-nucleus RNA-Seq reveals singular gene signatures of human ductal cells during adaptation to insulin resistance
JCI Insight. 2022; 7, e15387725.
Magenheim, J. ∙ Maestro, M.A. ∙ Sharon, N. ...
Matters arising: Insufficient evidence that pancreatic beta cells are derived from adult ductal Neurog3-expressing progenitors
Cell Stem Cell. 2023; 30:488-497.e326.
Klein, D. ∙ Álvarez-Cubela, S. ∙ Lanzoni, G. ...
BMP-7 Induces Adult Human Pancreatic Exocrine-to-Endocrine Conversion
Diabetes. 2015; 64:4123-413427.
Qadir, M.M.F. ∙ Álvarez-Cubela, S. ∙ Klein, D. ...
P2RY1/ALK3-Expressing Cells within the Adult Human Exocrine Pancreas Are BMP-7 Expandable and Exhibit Progenitor-like Characteristics
Cell Rep. 2018; 22:2408-242028.
Qadir, M.M.F. ∙ Álvarez-Cubela, S. ∙ Klein, D. ...
Single-cell resolution analysis of the human pancreatic ductal progenitor cell niche
Proc. Natl. Acad. Sci. USA. 2020; 117:10876-1088729.
Ngara, M. ∙ Wierup, N.
Lessons from single-cell RNA sequencing of human islets
Diabetologia. 2022; 65:1241-125030.
Elgamal, R.M. ∙ Kudtarkar, P. ∙ Melton, R.L. ...
An integrated map of cell type-specific gene expression in pancreatic islets
Preprint atbioRxiv. 2023;31.
Kaestner, K.H. ∙ Powers, A.C. ∙ Naji, A., HPAP Consortium
NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP)
Diabetes. 2019; 68:1394-140232.
Xin, Y. ∙ Adler, C. ∙ Kim, J. ...
Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets.
J. Vis. Exp. 2019; PMID: 3138084733.
Hao, Y. ∙ Hao, S. ∙ Andersen-Nissen, E. ...
Integrated analysis of multimodal single-cell data
Cell. 2021; 184:3573-3587.e2934.
Charytonowicz, D. ∙ Brody, R. ∙ Sebra, R.
Interpretable and context-free deconvolution of multi-scale whole transcriptomic data with UniCell deconvolve
Nat. Commun. 2023; 14:135035.
Elgamal, R.M. ∙ Kudtarkar, P. ∙ Melton, R.L. ...
An integrated map of cell type-specific gene expression in pancreatic islets
Diabetes. 2023; 72:1719-172836.
Walker, J.T. ∙ Saunders, D.C. ∙ Rai, V. ...
Genetic risk converges on regulatory networks mediating early type 2 diabetes
Nature. 2023; 624:621-62937.
Dann, E. ∙ Henderson, N.C. ∙ Teichmann, S.A. ...
Differential abundance testing on single-cell data using k-nearest neighbor graphs
Nat. Biotechnol. 2022; 40:245-25338.
Gregg, B.E. ∙ Moore, P.C. ∙ Demozay, D. ...
Formation of a human beta-cell population within pancreatic islets is set early in life
J. Clin. Endocrinol. Metab. 2012; 97:3197-320639.
Kassem, S.A. ∙ Ariel, I. ∙ Thornton, P.S. ...
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
Diabetes. 2000; 49:1325-133340.
Patil, A.R. ∙ Schug, J. ∙ Naji, A. ...
Single-cell expression profiling of islets generated by the Human Pancreas Analysis Program
Nat. Metab. 2023; 5:713-71541.
Grun, D. ∙ Muraro, M.J. ∙ Boisset, J.C. ...
De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data
Cell Stem Cell. 2016; 19:266-27742.
Muraro, M.J. ∙ Dharmadhikari, G. ∙ Grun, D. ...
A Single-Cell Transcriptome Atlas of the Human Pancreas
Cell systems. 2016; 3:385-394.e38343.
Enge, M. ∙ Arda, H.E. ∙ Mignardi, M. ...
Single-Cell Analysis of Human Pancreas Reveals Transcriptional Signatures of Aging and Somatic Mutation Patterns
Cell. 2017; 171:321-330.e1444.
Kang, R.B. ∙ Li, Y. ∙ Rosselot, C. ...
Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes beta-cell subpopulations with dynamic transcriptome profiles
Genome Med. 2023; 15:3045.
Lawlor, N. ∙ George, J. ∙ Bolisetty, M. ...
Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes
Genome Res. 2017; 27:208-22246.
Shrestha, S. ∙ Erikson, G. ∙ Lyon, J. ...
Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress
Sci. Adv. 2022; 8, eabo393247.
Dominguez Gutierrez, G. ∙ Kim, J. ∙ Lee, A.H. ...
Gene Signature of the Human Pancreatic epsilon Cell
Endocrinology. 2018; 159:4023-403248.
Augsornworawat, P. ∙ Hogrebe, N.J. ∙ Ishahak, M. ...
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Nat. Cell Biol. 2023; 25:904-91649.
Chiou, J. ∙ Zeng, C. ∙ Cheng, Z. ...
Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk
Nat. Genet. 2021; 53:455-46650.
Augsornworawat, P. ∙ Maxwell, K.G. ∙ Velazco-Cruz, L. ...
Single-Cell Transcriptome Profiling Reveals beta Cell Maturation in Stem Cell-Derived Islets after Transplantation
Cell Rep. 2020; 32, 10806751.
Segerstolpe, Å. ∙ Palasantza, A. ∙ Eliasson, P. ...
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Cell Metabol. 2016; 24:593-60752.
Wang, Y.J. ∙ Schug, J. ∙ Won, K.J. ...
Single-Cell Transcriptomics of the Human Endocrine Pancreas
Diabetes. 2016; 65:3028-303853.
Shrestha, S. ∙ Saunders, D.C. ∙ Walker, J.T. ...
Combinatorial transcription factor profiles predict mature and functional human islet alpha and beta cells
JCI Insight. 2021; 6, e15162154.
Wang, P. ∙ Karakose, E. ∙ Argmann, C. ...
Disrupting the DREAM complex enables proliferation of adult human pancreatic beta cells
J. Clin. Invest. 2022; 132, e15708655.
Collombat, P. ∙ Xu, X. ∙ Ravassard, P. ...
The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells
Cell. 2009; 138:449-46256.
Zhang, Y. ∙ Fava, G.E. ∙ Wang, H. ...
PAX4 Gene Transfer Induces alpha-to-beta Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment
Mol. Ther. 2016; 24:251-26057.
Chakravarthy, H. ∙ Gu, X. ∙ Enge, M. ...
Converting Adult Pancreatic Islet alpha Cells into beta Cells by Targeting Both Dnmt1 and Arx
Cell Metabol. 2017; 25:622-63458.
Li, J. ∙ Casteels, T. ∙ Frogne, T. ...
Artemisinins Target GABA(A) Receptor Signaling and Impair alpha Cell Identity
Cell. 2017; 168:86-100.e1559.
Ben-Othman, N. ∙ Vieira, A. ∙ Courtney, M. ...
Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis
Cell. 2017; 168:73-85.e1160.
Ackermann, A.M. ∙ Moss, N.G. ∙ Kaestner, K.H.
GABA and Artesunate Do Not Induce Pancreatic alpha-to-beta Cell Transdifferentiation In Vivo
Cell Metabol. 2018; 28:787-792.e361.
van der Meulen, T. ∙ Lee, S. ∙ Noordeloos, E. ...
Artemether Does Not Turn alpha Cells into beta Cells
Cell Metabol. 2018; 27:218-225.e462.
Xiao, X. ∙ Guo, P. ∙ Shiota, C. ...
Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes
Cell Stem Cell. 2018; 22:78-90.e463.
Shapira, S.N. ∙ Naji, A. ∙ Atkinson, M.A. ...
Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program
Cell Metabol. 2022; 34:1906-191364.
Hart, N.J. ∙ Powers, A.C.
Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Diabetologia. 2019; 62:212-22265.
Title, A.C. ∙ Karsai, M. ∙ Mir-Coll, J. ...
Evaluation of the Effects of Harmine on beta-cell Function and Proliferation in Standardized Human Islets Using 3D High-Content Confocal Imaging and Automated Analysis
Front. Endocrinol. 2022; 13, 85409466.
Fleming, S.J. ∙ Chaffin, M.D. ∙ Arduini, A. ...
Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Preprint atbioRxiv. 2022;67.
Korsunsky, I. ∙ Millard, N. ∙ Fan, J. ...
Fast, sensitive and accurate integration of single-cell data with Harmony
Nat. Methods. 2019; 16:1289-129668.
Bergen, V. ∙ Lange, M. ∙ Peidli, S. ...
Generalizing RNA velocity to transient cell states through dynamical modeling
Nat. Biotechnol. 2020; 38:1408-141469.
La Manno, G. ∙ Soldatov, R. ∙ Zeisel, A. ...
RNA velocity of single cells
Nature. 2018; 560:494-49870.
Virshup, I. ∙ Rybakov, S. ∙ Theis, F.J. ...
anndata: Annotated data
Preprint atbioRxiv. 2021;71.
Wolf, F.A. ∙ Angerer, P. ∙ Theis, F.J.
SCANPY: large-scale single-cell gene expression data analysis
Genome Biol. 2018; 19:1572.
Wolf, F.A. ∙ Hamey, F.K. ∙ Plass, M. ...
PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells
Genome Biol. 2019; 20:5973.
Lange, M. ∙ Bergen, V. ∙ Klein, M. ...
CellRank for directed single-cell fate mapping
Nat. Methods. 2022; 19:159-17074.
Van de Sande, B. ∙ Flerin, C. ∙ Davie, K. ...
A scalable SCENIC workflow for single-cell gene regulatory network analysis
Nat. Protoc. 2020; 15:2247-227675.
Waskom, M.
seaborn: statstical data visualization
J. Open Source Softw. 2021; 6:3021Gerelateerde artikelen
- Diabetes medicijn Ozempic (Semaglutide) vermindert aanzienlijk het risico op ernstige nierproblemen, ernstige cardiovasculaire gebeurtenissen en overlijden bij mensen met diabetes type 2 en chronische nierziekte
- Diabetici hebben grotere kans op krijgen van kanker en ook veel grotere kans - ca. 40% - daaraan te overlijden.
- Algemene informatie preventie
Plaats een reactie ...
Reageer op "Diabetes: Harmine, een natuurlijke alkaloide, blijkt de insuline productie te herstellen bij diabetes patienten en lijkt uitstekende behandeling om diabetes 1 en 2 te genezen"